Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100663932 | 10066393 | 2 | F | 20121204 | 20150624 | 20140408 | 20150630 | EXP | PHHO2014US004921 | NOVARTIS | 50.08 | YR | M | Y | 96.10000 | KG | 20150630 | N | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100663932 | 10066393 | 1 | PS | AFINITOR | EVEROLIMUS | 1 | Oral | 5 MG, QD | 70 | MG | U | 22334 | 5 | MG | TABLET | QD | |||
| 100663932 | 10066393 | 2 | SS | SORAFENIB | SORAFENIB | 1 | Oral | 400 MG, BID | 11200 | MG | U | 0 | 400 | MG | BID | ||||
| 100663932 | 10066393 | 3 | C | DEXAMETHASONE. | DEXAMETHASONE | 1 | Unknown | 1 MG, BID | D | 0 | 1 | MG | BID | ||||||
| 100663932 | 10066393 | 4 | C | LOVENOX | ENOXAPARIN SODIUM | 1 | Subcutaneous | 100 MG, Q12H | U | 0 | 100 | MG | Q12H | ||||||
| 100663932 | 10066393 | 5 | C | LAMICTAL | LAMOTRIGINE | 1 | Unknown | 200 MG, BID | D | 0 | 200 | MG | BID | ||||||
| 100663932 | 10066393 | 6 | C | CELEXA | CITALOPRAM HYDROBROMIDE | 1 | Oral | 20 MG, QD | D | 0 | 20 | MG | QD | ||||||
| 100663932 | 10066393 | 7 | C | COZAAR | LOSARTAN POTASSIUM | 1 | Oral | 25 MG, QD | D | 0 | 25 | MG | QD | ||||||
| 100663932 | 10066393 | 8 | C | LEVETIRACETAM. | LEVETIRACETAM | 1 | Unknown | 1500 MG Q AM AND 2000 MG Q PM | D | 0 | |||||||||
| 100663932 | 10066393 | 9 | C | LIPITOR | ATORVASTATIN CALCIUM | 1 | Oral | 10 MG, QD | D | 0 | 10 | MG | QD | ||||||
| 100663932 | 10066393 | 10 | C | PROTONIX | PANTOPRAZOLE SODIUM | 1 | Oral | 40 MG, QD | D | 0 | 40 | MG | QD | ||||||
| 100663932 | 10066393 | 11 | C | VIMPAT | LACOSAMIDE | 1 | Oral | 100 MG, BID | D | 0 | 100 | MG | BID | ||||||
| 100663932 | 10066393 | 12 | C | FISH OIL | FISH OIL | 1 | Oral | 1 DF, BID | D | 0 | 1 | DF | BID | ||||||
| 100663932 | 10066393 | 13 | C | ATIVAN | LORAZEPAM | 1 | Oral | 1 MG, BID | D | 0 | 1 | MG | BID |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 100663932 | 10066393 | 1 | Glioblastoma |
| 100663932 | 10066393 | 2 | Glioblastoma |
| 100663932 | 10066393 | 3 | Product used for unknown indication |
| 100663932 | 10066393 | 4 | Product used for unknown indication |
| 100663932 | 10066393 | 5 | Product used for unknown indication |
| 100663932 | 10066393 | 6 | Product used for unknown indication |
| 100663932 | 10066393 | 7 | Product used for unknown indication |
| 100663932 | 10066393 | 8 | Product used for unknown indication |
| 100663932 | 10066393 | 9 | Product used for unknown indication |
| 100663932 | 10066393 | 10 | Product used for unknown indication |
| 100663932 | 10066393 | 11 | Product used for unknown indication |
| 100663932 | 10066393 | 12 | Product used for unknown indication |
| 100663932 | 10066393 | 13 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 100663932 | 10066393 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 100663932 | 10066393 | Gait disturbance | |
| 100663932 | 10066393 | Haemorrhage intracranial |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 100663932 | 10066393 | 1 | 20121121 | 20121204 | 0 | |
| 100663932 | 10066393 | 2 | 20121121 | 20121204 | 0 | |
| 100663932 | 10066393 | 4 | 20121205 | 0 |